Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Clean Water Enforcement and Compliance Improvement Act of 2003
Client: ZERO PROSTATE CANCER · Firm: ZERO PROSTATE CANCER
HR 1624/S913 Medicare coverage for oral anticancer drugs
Clean Water Enforcement and Compliance Improvement Act of 2003
Client: ZERO PROSTATE CANCER · Firm: ZERO PROSTATE CANCER
HR 1624/S913 Medicare coverage for oral anticancer drugs
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ZERO PROSTATE CANCER via ZERO PROSTATE CANCER
2003 · mid_year · MM
Appropriations: Cancer Research; Prostate Cancer Research
HR 1624/S913 Medicare coverage for oral anticancer drugs
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
Source: Senate LDA
Deposit Insurance Fairness and Economic Opportunity Act
Client: ZERO PROSTATE CANCER · Firm: ZERO PROSTATE CANCER
HR 1624/S913 Medicare coverage for oral anticancer drugs
Deposit Insurance Fairness and Economic Opportunity Act
Client: ZERO PROSTATE CANCER · Firm: ZERO PROSTATE CANCER
HR 1624/S913 Medicare coverage for oral anticancer drugs
Access to Cancer Therapies Act of 2001
Client: ZERO PROSTATE CANCER · Firm: ZERO PROSTATE CANCER
HR 1624/S913 Provide Medicaire/Medicaid coverage for oral anticancer drugs
Access to Cancer Therapies Act of 2001
Client: ZERO PROSTATE CANCER · Firm: ZERO PROSTATE CANCER
HR 1624/S913 Provide Medicaire/Medicaid coverage for oral anticancer drugs
ZERO PROSTATE CANCER via ZERO PROSTATE CANCER
2003 · mid_year · MM
HR 1624/S913 Medicare coverage for oral anticancer drugs
Appropriations: Cancer Research; Prostate Cancer Research
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
ZERO PROSTATE CANCER via ZERO PROSTATE CANCER
2002 · year_end · YY
Preferred drug list programs
HR 1624/S913 Provide Medicaire/Medicaid coverage for oral anticancer drugs
Appropriations: Cancer research; Prostate cancer research
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
ZERO PROSTATE CANCER via ZERO PROSTATE CANCER
2000 · mid_year · MM
Filing targets: Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
ZERO PROSTATE CANCER via ZERO PROSTATE CANCER
1999 · year_end · YY
Filing targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)